Recommendations for patient involvement in health technology assessment in Central and Eastern European countries
Ivett Jakab,Maria Dimitrova,François Houÿez,Tamás Bereczky,Miroslava Fövényes,Zorana Maravic,Ivica Belina,Christian Andriciuc,Krisztina Tóth,Oresta Piniazhko,Rok Hren,Iñaki Gutierrez-Ibarluzea,Marcin Czech,Tomas Tesar,Maciej Niewada,László Lorenzovici,Maria Kamusheva,Manoela Manova,Alexandra Savova,Zornitsa Mitkova,Konstantin Tachkov,Bertalan Németh,Zsuzsanna Ida Petykó,Dalia Dawoud,Diana Delnoij,Saskia Knies,Wim Goettsch,Zoltán Kaló
DOI: https://doi.org/10.3389/fpubh.2023.1176200
2023-07-03
Abstract:Introduction: Meaningful patient involvement in health technology assessment (HTA) is essential in ensuring that the interests of the affected patient population, their families, and the general public are accurately reflected in coverage and reimbursement decisions. Central and Eastern European (CEE) countries are generally at less advanced stages of implementing HTA, which is particularly true for patient involvement activities. As part of the Horizon2020 HTx project, this research aimed to form recommendations for critical barriers to patient involvement in HTA in CEE countries. Methods: Built on previous research findings on potential barriers, a prioritisation survey was conducted online with CEE stakeholders. Recommendations for prioritised barriers were formed through a face-to-face workshop by CEE stakeholders and HTx experts. Results: A total of 105 stakeholders from 13 CEE countries completed the prioritisation survey and identified 12 of the 22 potential barriers as highly important. The workshop had 36 participants representing 9 CEE countries, and 5 Western European countries coming together to discuss solutions in order to form recommendations based on best practices, real-life experience, and transferability aspects. Stakeholder groups involved in both phases included HTA organisation representatives, payers, patients, caregivers, patient organisation representatives, patient experts, health care providers, academic and non-academic researchers, health care consultants and health technology manufacturers/providers. As a result, 12 recommendations were formed specified to the CEE region's context, but potentially useful for a broader geographic audience. Conclusion: In this paper, we present 12 recommendations for meaningful, systematic, and sustainable patient involvement in HTA in CEE countries. Our hope is that engaging more than a hundred CEE stakeholders in the study helped to spread awareness of the importance and potential of patient involvement and that the resulting recommendations provide tangible steps for the way forward. Future studies shall focus on country-specific case studies of the implemented recommendations.